OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4
Zhiyong Wang, Victoria H. Wu, Michael M. Allevato, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 142

Showing 1-25 of 142 citing articles:

Head and neck squamous cell carcinoma
Daniel E. Johnson, Barbara Burtness, C. René Leemans, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 2802

Biomaterial-mediated modulation of oral microbiota synergizes with PD-1 blockade in mice with oral squamous cell carcinoma
Diwei Zheng, Wei‐Wei Deng, Wenfang Song, et al.
Nature Biomedical Engineering (2021) Vol. 6, Iss. 1, pp. 32-43
Closed Access | Times Cited: 106

Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC
Robert Saddawi‐Konefka, Aoife O’Farrell, Farhoud Faraji, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 95

A Dual‐Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis
Wen Su, Wei Qiu, Shu‐Jin Li, et al.
Advanced Materials (2022) Vol. 35, Iss. 11
Closed Access | Times Cited: 72

Tumor heterogeneity: preclinical models, emerging technologies, and future applications
Marco Proietto, Martina Crippa, C. Damiani, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 56

Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy
Liang Zhang, Boxin Zhang, Mengjie Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2

BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse
Lingfei Jia, Wuchang Zhang, Cun‐Yu Wang
Cell stem cell (2020) Vol. 27, Iss. 2, pp. 238-253.e6
Open Access | Times Cited: 115

Mouse Tumor Models for Advanced Cancer Immunotherapy
Daria S. Chulpanova, Kristina V. Kitaeva, Catrin S. Rutland, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4118-4118
Open Access | Times Cited: 106

circFAT1 Promotes Cancer Stemness and Immune Evasion by Promoting STAT3 Activation
Lingfei Jia, Yilun Wang, Cun‐Yu Wang
Advanced Science (2021) Vol. 8, Iss. 13
Open Access | Times Cited: 100

QuPath: The global impact of an open source digital pathology system
Matthew P. Humphries, Perry Maxwell, Manuel Salto‐Tellez
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 852-859
Open Access | Times Cited: 79

Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies
Yu Zhang, Chengzhong Lin, Zheqi Liu, et al.
Cell Metabolism (2022) Vol. 34, Iss. 12, pp. 1999-2017.e10
Open Access | Times Cited: 70

Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer
Zhiyong Wang, Yusuke Goto, Michael M. Allevato, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 60

TDO2+ myofibroblasts mediate immune suppression in malignant transformation of squamous cell carcinoma
Simeng Hu, Huanzi Lu, Wenqiang Xie, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 19
Open Access | Times Cited: 50

Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas
Yinglu Li, Elizabeth M. Goldberg, Xiao Chen, et al.
Molecular Cell (2022) Vol. 82, Iss. 20, pp. 3901-3918.e7
Open Access | Times Cited: 42

The GPCR–Gαs–PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure
Victoria H. Wu, Bryan S. Yung, Farhoud Faraji, et al.
Nature Immunology (2023) Vol. 24, Iss. 8, pp. 1318-1330
Closed Access | Times Cited: 33

Exploring animal models in oral cancer research and clinical intervention: A critical review
Danial Khayatan, Ahmed Hussain, Hamid Tebyaniyan
Veterinary Medicine and Science (2023) Vol. 9, Iss. 4, pp. 1833-1847
Open Access | Times Cited: 30

CTLA-4 blockade induces tumor pyroptosis via CD8+ T cells in head and neck squamous cell carcinoma
Shuo Wang, Zhi‐Zhong Wu, Su‐Wen Zhu, et al.
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 2154-2168
Closed Access | Times Cited: 27

Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV HNSCC
Hao Li, Sailing Zhu, Jiehua Zhou, et al.
Journal of Dental Research (2023) Vol. 102, Iss. 6, pp. 678-688
Closed Access | Times Cited: 26

Preclinical models in head and neck squamous cell carcinoma
Patricia Cháves, Marı́a J. Garrido, Javier Oliver, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 10, pp. 1819-1827
Open Access | Times Cited: 25

Dysregulated Wnt/β-catenin signaling confers resistance to cuproptosis in cancer cells
Yuan‐Tong Liu, Lei Chen, Shu‐Jin Li, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 11, pp. 1452-1466
Closed Access | Times Cited: 10

m1A inhibition fuels oncolytic virus-elicited antitumor immunity via downregulating MYC/PD-L1 signaling
Shu‐Jin Li, Feng Tian, Yuan‐Tong Liu, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9

Tumor-Intrinsic SIRPA Drives Pyroptosis Evasion in Head and Neck Cancer
Andrew Song, Qian‐Qian Yang, Wenbiao Wang, et al.
Journal of Dental Research (2025)
Closed Access | Times Cited: 1

Squamous cell cancers of the aero-upper digestive tract: A unified perspective on biology, genetics, and therapy
Brian S. Henick, Alison Taylor, Hiroshi Nakagawa, et al.
Cancer Cell (2025) Vol. 43, Iss. 2, pp. 178-194
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top